Form 8-K - Current report:
SEC Accession No. 0001104659-21-105208
Filing Date
2021-08-13
Accepted
2021-08-13 17:01:17
Documents
13
Period of Report
2021-08-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2125142d1_8k.htm   iXBRL 8-K 24801
2 EXHIBIT 99.1 tm2125142d1_ex99-1.htm EX-99.1 15344
  Complete submission text file 0001104659-21-105208.txt   219423

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sesn-20210813.xsd EX-101.SCH 3188
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sesn-20210813_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sesn-20210813_pre.xml EX-101.PRE 22712
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2125142d1_8k_htm.xml XML 3591
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211173181
SIC: 2834 Pharmaceutical Preparations